Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to improving the lives of people with neurological and psychiatric disorders. They specialize in discovering, developing, and commercializing innovative therapeutics, primarily focused on human channelopathies. Their expertise in ion channel drug discovery stems from their understanding of the genetics of channelopathies, combined with proprietary biology and medicinal chemistry assets. Xenon's lead molecule, azetukalner, is a potent Kv7 potassium channel opener being developed for the treatment of epilepsy and major depressive disorder, with potential applications for other neurological disorders.

Xenon is actively engaged in clinical trials for azetukalner, including Phase 3 studies for focal onset seizures and primary generalized tonic-clonic seizures. They are also collaborating with Neurocrine Biosciences on the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor for pediatric patients with SCN8A developmental and epileptic encephalopathy. Beyond their clinical programs, Xenon is leveraging their ion channel expertise to develop promising drug candidates that target sodium and potassium channels, aiming to advance multiple candidates into IND-enabling studies in the near future.

Xenon Pharmaceuticals offers flexible work arrangements for some roles, with remote work options available for certain positions. The company has offices in Burnaby, BC, Canada, and Needham, MA, USA, and clearly states in job postings if a role can be performed remotely. This allows employees to potentially achieve a better work-life balance and allows Xenon to attract talent from a wider pool of candidates.

Xenon Pharmaceuticals offers a comprehensive benefits package to its employees, including a competitive total compensation package comprised of base salary, bonus, and stock options, along with a retirement savings program. In addition to health, dental, and vision insurance, they provide coverage for disability and life insurance, as well as access to an Employee Assistance Program (EAP). Employees also have access to formal training and development opportunities, including management and leadership training, attendance at relevant conferences, and coverage of relevant professional membership dues. A variety of employee recognition programs, an active social committee that plans employee events, and support for local charities and volunteerism are also available.

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to improving the lives of people living with neurological and psychiatric disorders. They focus on discovering, developing, and commercializing innovative therapeutics to address areas of high unmet medical need, such as epilepsy and depression. Their mission is to deliver innovative medicines that provide a brighter future for patients suffering from these conditions.

Xenon Pharmaceuticals fosters a positive and inclusive workplace culture that values collaboration, ambition, resilience, ethics, and science. They are committed to diversity and creating a safe, inclusive environment where everyone feels heard. They offer various programs to support employees' professional growth and well-being, including financial benefits, health insurance, professional development opportunities, and social activities.

Xenon Pharmaceuticals Inc. values diversity, equity, and inclusion, striving to create a positive and inclusive workplace that celebrates the diverse backgrounds, experiences, and opinions of its employees. The company recognizes that fostering a safe and inclusive environment where everyone feels heard strengthens its workplace culture and creates a healthier and more positive atmosphere. Xenon is committed to cultivating and celebrating diversity in the workplace, believing that it is a great asset to the company.